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Objectives: The effect of mild-to-moderate elevation of preoperative serum
creatinine levels on morbidity and mortality from coronary artery bypass
grafting has not been investigated in a large multivariable model incorporat-
ing preoperative and intraoperative variables. Our first objective was to ascer-
tain the effect of a mild-to-moderate elevation in the preoperative serum cre-
atinine level on the need for mechanical renal support; the duration of special
care and total postoperative stay; the occurrence of infective, respiratory, and
neurologic complications; and hospital mortality. Our second objective was to
ascertain which patient variables contributed to an increase in the serum cre-
atinine level in association with coronary artery bypass grafting.
Methods: A total of 1427 patients who had no known pre-existing renal dis-
ease and who were undergoing first-time coronary artery bypass grafting
with cardiopulmonary bypass were recruited for the study. Patients were
divided, on the basis of preoperative serum creatinine level, into 3 groups as
follows: creatinine level of less than 130 µmol · L–1; creatinine level of 130
to 149 µmol · L–1; and creatinine level of 150 µmol · L–1 or greater. A mul-
tivariable stepwise logistic regression analysis was used, and variables sig-
nificant at the 5% level were included when developing the final multivari-
able models.
Results: Multivariable analysis showed that elevation of the preoperative
serum creatinine level to 130 µmol · L–1 or greater increased the likelihood
of needing mechanical renal support postoperatively (P < .001), as well as
the need for postoperative special care (P < .001) and total hospital stay 
(P < .001). In-hospital mortality was also significantly elevated as the pre-
operative creatinine level rose to 130 to 149 µmol · L–1 (P = .045) and to 150
µmol · L–1 or greater (P < .001). It was further observed that patients with
preoperative serum creatinine levels of 130 to 149 µmol · L–1 (P = .02),
patients with preoperative serum creatinine levels of 150 µmol · L–1 or
greater (P = .001), hypertensive patients (P = .007), patients with angina of
New York Heart Association class III or greater (P = .001), patients having a
nonelective operation (P = .002), and patients having a prolonged cardiopul-
monary bypass time (P = .008) had a significantly greater increase in the
serum creatinine level as a result of coronary artery bypass grafting. Of par-
ticular note was the finding that the method of myocardial protection (car-
dioplegia or crossclamp fibrillation) did not significantly influence in-hospi-
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C ardiac operations adversely affect renal function,causing varying degrees of postoperative renal
impairment.1,2 In the presence of advanced preopera-
tive chronic renal failure, the deleterious influence of
cardiopulmonary bypass is further increased.3,4 The
precise level at which renal dysfunction begins to
adversely affect outcome is unknown. Clinical impres-
sion suggests that even mild or moderate elevations of
serum creatinine levels have an adverse effect on out-
come. One of the first studies attempting to address this
issue focused on moderate (>150 µmol · L–1) elevations
of preoperative serum creatinine levels.5 In a more
recent study of 93 patients, Durmaz and colleagues6
looked at the effect of milder elevations of the preoper-
ative serum creatinine level and found levels greater
than 2.5 mg/dL (>200 µmol · L–1) in non–dialysis-
dependent patients to increase the risk of postoperative
dialysis, prolonged hospital stay and in-hospital mor-
tality. However, the effect of a more borderline eleva-
tion of preoperative serum creatinine levels has not
been investigated in a large multivariable model that
included other potential preoperative and intraoperative
contributors to morbidity and mortality. This study was
designed to address these issues.
The first objective of the study was to identify the
effect on morbidity and mortality of mild-to-moderate
elevation of the preoperative serum creatinine level in
non–dialysis-dependent patients undergoing coronary
artery bypass grafting. The second objective was to
identify the factors that contribute to any observed
deterioration of renal function after coronary artery
bypass grafting.
Methods
Patient selection. The computerized prospective cardiac
surgical database at the Hammersmith Hospital (London,
United Kingdom) maintains data on all cardiac operations
performed at the hospital. We recruited 1427 patients operat-
ed on between June 1993 and December 1997 for the study.
Criteria for selection were that patients were having first-time
coronary artery bypass grafting and that no known acute or
chronic renal disease pre-existed. The highest preoperative
serum creatinine level within 7 days preceding the operation
was taken as the preoperative creatinine level. Patients were
grouped on the basis of preoperative creatinine level into 1 of
3 groups. The postoperative creatinine level was taken as the
highest value in the first 28 days after the operation.
Creatinine levels were measured for a minimum of 3 days
after peak values were reached on all patients to confirm that
levels were decreasing. The preoperative and intraoperative
variables used for the study, along with the preoperative cre-
atinine groups into which they were categorized, are shown in
Table I. The study cohort consisted of 1197 (83.8%) male and
230 (16.2%) female patients. Of these patients, 1166 (81.7%)
were less than 70 years of age, and 261 (18.3%) were 70
years of age or older. The preoperative creatinine level was
not normally distributed, with a median of 98 µmol · L–1 and
an interquartile range of 87 to 110 µmol · L–1. Elevation of
the preoperative creatinine level to 150 µmol · L–1 or greater
in these patients with no known pre-existing renal disease
was defined as moderate elevation. Values approximately
above the upper limit of the laboratory normal range but
below 150 µmol · L–1 were defined as mild elevation. Thus,
66 (4.6%) patients had a mildly elevated creatinine level of
130 to 149 µmol · L–1, and 54 (3.8%) had a moderately ele-
vated creatinine level of 150 µmol · L–1 or greater. A total of
1307 (91.6%) patients had preoperative serum creatinine lev-
els of less than 130 µmol · L–1.
Surgical technique. The mean number of grafts per
patient was 3.3 ± 0.8, and the mean cardiopulmonary bypass
time was 77.1 ± 24.3 minutes. The method of myocardial pro-
tection used was crossclamp fibrillation in 484 (33.9%)
patients and cardioplegia in 943 (66.1%) patients. Cardio-
pulmonary bypass was performed by means of aortocaval can-
nulation, a Stockert roller pump (Stockert Instrumente,
Munich, Germany) and a Bard (C. R. Bard, Inc, Murray Hill,
NJ) or Quadrox hollow-fiber membrane oxygenator (Jostra
Medizintechnik AG). The mean blood pressure on cardiopul-
monary bypass was maintained at 50 to 60 mm Hg. The low-
est core temperature in degrees Celsius was noted as the core
temperature of the body during the operation.
Statistical analysis. Analysis of the data was per-
formed with Stata-6 software (Stata Corporation, College
Station, Tex). Univariate analysis was initially performed to
ascertain associations between explanatory variables and
outcome, χ2 tests were used for categoric variables, and 2-
sample t tests were used for the continuous variables, core
temperature, and cardiopulmonary bypass time. Stepwise
logistic multivariable regression analysis was used with
both forward and backward variable selection. Variables
significant at the 5% level were retained in the final multi-
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Conclusions: A mild elevation (130-149 µmol · L–1) in the preoperative
serum creatinine level significantly increases the need for mechanical renal
support, the duration of special care and total postoperative stay, and the in-
hospital mortality. As the preoperative serum creatinine level increases fur-
ther (≥150 µmol · L–1), this effect is more pronounced. No significant dif-
ference in outcome was observed between the use of cardioplegia or
crossclamp fibrillation for myocardial protection. (J Thorac Cardiovasc Surg
2001;121:1083-9)
variable models. In-hospital mortality is used for the mor-
tality analysis. Variables considered for inclusion in the
multivariable models were as follows: sex, age, diabetes
mellitus, hypertension, hypercholesterolemia, New York
Heart Association (NYHA) grade of angina, previous
myocardial infarction, smoking, ejection fraction, cardio-
genic shock, number of diseased coronary arteries, left main
stem coronary stenosis of greater than 50%, preoperative
urea, surgical priority, type of myocardial protection, core
temperature during the operation, and cardiopulmonary
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Table I. Preoperative and intraoperative variables used in developing all multivariable models presented 
in the study
Creatinine level Creatinine level Creatinine level 
Variable <130 µmol · L–1 130-149 µmol · L–1 ≥150 µmol · L–1
Sex
Male 1094 (83.7%) 60 (90.9%) 43 (79.6%)
Female 213 (16.3%) 6 (9.1%) 11 (20.4%)
Age (y)
<70 1088 (83.2%) 42 (63.6%) 36 (66.7%)
≥70 219 (16.8%) 24 (36.4%) 18 (33.3%)
Diabetes mellitus
No 1008 (77.1%) 44 (66.7%) 35 (64.8%)
Yes 299 (22.9%) 22 (33.3%) 19 (35.2%)
Hypertension
No 754 (57.7%) 37 (56.1%) 18 (33.3%)
Yes 553 (42.3%) 29 (43.9%) 36 (66.7%)
Hypercholesterolemia
No 763 (58.4%) 40 (60.6%) 39 (72.2%)
Yes 544 (41.6%) 26 (39.4%) 15 (27.8%)
Angina
≤NYHA II 789 (60.4%) 37 (56.1%) 26 (48.1%)
≥NYHA III 518 (39.6%) 29 (43.9%) 28 (59.9%)
Past myocardial infarction
No 570 (43.6%) 28 (42.4%) 21 (38.9%)
Yes 737 (56.4%) 38 (57.6%) 33 (61.1%)
Smoking
Never 406 (31.1%) 17 (25.8%) 17 (31.5%)
Ever 901 (68.9%) 49 (74.2%) 37 (68.5%)
Ejection fraction
≥30% 1178 (90.1%) 42 (63.6%) 39 (72.2%)
<30% 129 (9.9%) 24 (36.4%) 15 (27.8%)
Cardiogenic shock
No 1287 (98.5%) 65 (98.5%) 53 (98.2%)
Yes 20 (1.5%) 1 (1.5%) 1 (1.8%)
Diseased coronaries
≤2 265 (20.3%) 17 (25.8%) 4 (7.4%)
>2 1042 (79.7%) 49 (74.25%) 50 (92.6%)
Left main stem stenosis >50%
No 1241 (95%) 57 (86.4%) 49 (90.7%)
Yes 66 (5%) 9 (13.6%) 5 (9.3%)
Preoperative urea
<7.5 mmol · L–1 1069 (81.8%) 21 (31.8%) 4 (7.4%)
≥7.5 mmol · L–1 238 (18.2%) 45 (68.2%) 50 (92.6%)
Surgical priority
Elective 983 (75.2%) 39 (59.1%) 29 (53.7%)
Nonelective 324 (24.8%) 27 (40.9%) 25 (46.3%)
Myocardial protection
Cardioplegia 871 (66.6%) 45 (68.2%) 27 (50%)
Crossclamp fibrillation 436 (33.4%) 21 (31.8%) 27 (50%)
Core temperature (°C)
Mean ± SD 32.7 ± 2.2 33.1 ± 2.2 32.6 ± 2
Cardiopulmonary bypass time (min)
Mean ± SD 77 ± 24.3 71.8 ± 24.5 85.5 ± 23
The number and percentage of patients within each preoperative creatinine group for the variable under consideration is shown unless otherwise indicated.
bypass time. Table I shows the distribution of these vari-
ables in the preoperative creatinine groups.
Results
Morbidity analysis. The effect of the preoperative
serum creatinine groups on the need for new mechani-
cal renal support (hemofiltration-hemodialysis), the
need for protracted special care (combined intensive
care and high-dependency unit) and total postoperative
stay, and the occurrence of pulmonary, neurologic, and
infective complications in the hospital were analyzed.
Of the 1427 patients in the study, 28 (2.0%) required
postoperative mechanical renal support. Because only
28 patients required postoperative mechanical renal
support, developing a model with the 3 preoperative
creatinine groups was likely to result in statistical over-
fitting, which is associated with type 1 errors (ie, where
a variable is incorrectly identified as significant). This
was addressed by combining the 2 higher creatinine
categories and reanalyzing as a creatinine level of less
than 130 µmol · L–1 or 130 µmol · L–1 or greater.
Multivariable analysis with all variables in Table I
showed a preoperative creatinine level of 130 µmol ·
L–1 or greater (P < .001), nonelective operation 
(P = .01), and female sex (P = .02) to increase the like-
lihood of needing mechanical renal support (Table II).
At this hospital, patients spend the first night after
operation in the intensive care unit and the second in
the high-dependency unit before transfer to the ward
the next morning. The median (interquartile range) for
special care stay was 2 (2-3) days and 7 (6-8) days for
the total postoperative hospital stay. A stay greater than
the 90th percentile was defined as prolonged. This
equated to a special care (combined intensive care and
high dependency) stay of greater than 3 days in 156
patients and a total postoperative stay of greater than 10
days in 160 patients. On multivariable analysis,
patients with a preoperative creatinine level of 130 to
149 µmol · L–1 were 3 times as likely (P < .001) and
patients with a preoperative creatinine level of 150
µmol · L–1 or greater were 3.9 times as likely (P < .001)
to have a prolonged special care stay than those with a
creatinine level of less than 130 µmol · L–1. Other fac-
tors contributing to a prolonged special care stay were
being 70 years of age or older (P = .007), having a pre-
operative left ventricular ejection fraction of less than
30% (P = .001), and having a prolonged cardiopul-
monary bypass time (P < .001; Table III). A preopera-
tive creatinine level of 130 µmol · L–1 or greater
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Table II.  Factors contributing significantly toward
needing postoperative mechanical renal support
Covariate Odds ratio P value 95% CI
Preoperative creatinine level
<130 µmol · L–1 1
≥130 µmol · L–1 24.43 <.001 10.37-57.52
Sex
Male 1
Female 2.95 .02 1.19-7.35
Surgical priority
Elective 1
Nonelective 3.13 .01 1.35-7.24
Multivariable analysis was done with all variables included in Table I. The 2
higher preoperative serum creatinine groups used in the remainder of the
study have been amalgamated to avoid statistical overfitting.
Table III.  Factors contributing significantly toward a
prolonged special care (combined intensive care and
high-dependency unit) stay of greater than 3 days
Covariate Odds ratio P value 95% CI
Preoperative creatinine level
<130 µmol · L–1 1
130-149 µmol · L–1 3.08 <.001 1.65-5.76
≥150 µmol · L–1 3.92 <.001 2.02-7.59
Age (y)
<70 1
≥70 1.73 .007 1.16-2.57
Left ventricular function
Ejection fraction ≥ 30% 1
Ejection fraction < 30% 2.15 .001 1.37-3.36
Cardiopulmonary bypass time
For increments of 10 min 1.18 <.001 1.11-1.27
Table IV.  Factors contributing significantly toward a
prolonged total postoperative hospital stay of greater
than 10 days
Covariate Odds ratio P value 95% CI
Preoperative creatinine level
<130 µmol · L–1 1
130-149 µmol · L–1 4.68 <.001 2.63-8.34
≥150 µmol · L–1 4.28 <.001 2.31-7.91
Sex
Male 1
Female 1.77 .007 1.17-2.68
Age (y)
<70 1
≥70 1.64 .013 1.11-2.42
Previous myocardial infarction
No 1
Yes 1.67 .005 1.16-2.39
Cardiopulmonary bypass time
For increments of 10 min 1.12 <.001 1.04-1.20
increased the likelihood of a prolonged total postoper-
ative hospital stay by over 4-fold (P < .001). Being a
woman (P = .007), being 70 years of age or older 
(P = .013), and having had a previous myocardial
infarction (P = .005), or having a prolonged cardiopul-
monary bypass time (P < .001) also contributed to a
prolonged total postoperative stay (Table IV). The pre-
operative serum creatinine level on multivariable
analysis was seen to be not a significant predictor of
pulmonary, neurologic, or infective complications.
Differences between the use of cardioplegia or cross-
clamp fibrillation were looked for in the multivariable
analysis. No significant difference was seen in the need
for mechanical renal support (P = .10), special care
stay (P = .67), or total postoperative hospital stay 
(P = .16).
Mortality analysis. In-hospital intraoperative or
postoperative death was defined as mortality for the
purposes of the study. There were 45 (3.2%) deaths.
The mortality for the 3 preoperative creatinine groups
is shown in Fig 1. The odds ratio for mortality on mul-
tivariable analysis was 3 times (P = .045) higher if the
preoperative creatinine level rose from less than 130
µmol · L–1 to 130 to 149 µmol · L–1. As the preopera-
tive creatinine level rose further to 150 µmol · L–1 or
greater, the odds ratio for mortality increased to 7 times
(P < .001) that of patients with a preoperative serum
creatinine level of less than 130 µmol · L–1. Other fac-
tors contributing to an increase in mortality on multi-
variable analysis were being female (P < .001), being
70 years of age or older (P = .004), having a preopera-
tive left ventricular ejection fraction of less than 30%
(P = .006), and having a prolonged cardiopulmonary
bypass time (P < .001; Table V). In contrast, no signif-
icant difference was present between the use of cardio-
plegia or crossclamp fibrillation on mortality (P = .21)
in the multivariable analysis.
Analysis of increase in serum creatinine level.
Having observed the effect of a mild-to-moderate
increase in the preoperative serum creatinine level on
outcome, we next studied the factors that contribute to
its increase after coronary artery bypass grafting. The
change between preoperative and postoperative creati-
nine level was not normal in distribution. The median
was an increase of 8.4% above the preoperative value,
with an interquartile range of –2.6% to 23.1%. An
increase in the serum creatinine level after the opera-
tion by 20% or greater of the preoperative value was
taken as a significant elevation and occurred in 401
(28.1%) patients. Multivariable analysis with all vari-
ables shown in Table I showed that patients with a pre-
operative creatinine level of 130 to 149 µmol · L–1 were
1.8 times as likely (P = .02) as patients with a preoper-
ative creatinine level of less than 130 µmol · L–1 to have
their serum creatinine level increase by 20% or greater
postoperatively, and patients with a preoperative creati-
nine level of 150 µmol · L–1 or greater were 2.5 times
as likely to have such a result (P = .001). Hypertensive
patients were 1.4 times as likely to have a significant
increase (P = .007) in their serum creatinine levels than
nonhypertensive patients. Patients with angina in
NYHA class III were 1.5 times as likely to have a 20%
or greater increase in their serum creatinine level 
(P = .001). Nonelective operations increased the likeli-
hood of a significant increase in the serum creatinine
level by 1.5 times (P = .002). For each 10-minute
increase in the cardiopulmonary bypass time, the like-
lihood of a 20% or greater increase in the serum crea-
tinine level increased 1.1 times (P = .008; Table VI).
Discussion
Serum creatinine level, despite not being as accurate
as measuring the glomerular filtration rate, is still the
most readily available clinical measurement of renal
function. The increase in morbidity and mortality asso-
ciated with dialysis-dependent renal disease is widely
recognized.3,4 An increased morbidity has also been
shown in association with moderately elevated serum
creatinine levels in patients with non–dialysis-depen-
dent renal insufficiency.5
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Fig 1. In-hospital mortality by preoperative creatinine group.
The mortality within each creatinine group is given as a per-
centage of the total patients within that group.
Despite suspicions that even creatinine levels only
mildly elevated above the laboratory normal range are
associated with increased morbidity and possibly mortal-
ity, confirmation from a large multivariable model includ-
ing preoperative and intraoperative factors has until now
been unavailable. In the design of this study we included,
in the multivariable analysis, other preoperative factors
that are known to be associated with renal dysfunction
and poor outcome. Despite including these risk factors in
the multivariable analysis, even a mild increase in the pre-
operative serum creatinine level over the normal range
significantly increased the risk of needing mechanical
renal support postoperatively, as well as prolonging the
special care and total postoperative hospital stay.
One of the most important observations from the
study was the pronounced effect a mild-to-moderate
elevation in the preoperative serum creatinine level had
on the mortality from coronary artery bypass grafting.
A recent study on the basis of the Veterans Affairs data-
base demonstrated that patients with a preoperative
serum creatinine level of 1.5 mg/dL to 3 mg/dL (120-
240 µmol · L–1) had an increased 30-day mortality after
coronary artery bypass grafting.7 The current study fur-
ther highlights the importance of the preoperative cre-
atinine level on mortality by demonstrating that the
effect is significant even at milder (130-149 µmol · L–1)
elevation of the preoperative serum creatinine level.
This is the first study in which this pronounced effect
has been seen in a multivariable model incorporating
both preoperative and intraoperative risk factors. The
large number of patients studied is likely to have helped
reveal this significant association. These results are
important because they identify the effect the preoper-
ative serum creatinine level has on morbidity and mor-
tality independent of the presence of other risk factors,
such as sex, age, left ventricular function, and car-
diopulmonary bypass time.
Analysis of the factors contributing to an increase in
creatinine level in association with coronary artery
bypass grafting showed that patients with higher pre-
operative serum creatinine levels were more likely to
show an increase in their creatinine levels of 20% or
greater above the preoperative levels. Patients with
higher preoperative serum creatinine levels are likely to
have a higher proportion of functionally borderline
glomeruli, which potentially are more susceptible to
deterioration of their function when exposed to the
insults of an operation. It was also seen that hyperten-
sive patients were more likely to have an increase in
serum creatinine levels as a result of an operation.
Hypertension contributes to progressive renal failure
by inducing myointimal hyperplasia of arcuate and
afferent arterioles, causing glomerular ischemia8
(hypertensive glomerularsclerosis), which is likely to
increase the susceptibility of the kidneys to cardiopul-
monary bypass. The greater increase in serum creati-
nine levels in patients with angina of NYHA class III
or greater is likely to be due to a greater likelihood of
concomitant renal vascular disease. The increase in
creatinine level was also seen to be greater with
increasing cardiopulmonary bypass times. Hemolysis
and release of free hemoglobin9 may increase with pro-
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Table V.  Factors contributing significantly toward
increased in-hospital mortality
Covariate Odds ratio P value 95% CI
Preoperative creatinine level
<130 µmol · L–1 1
130-149 µmol · L–1 3.00 .045 1.03-8.79 
≥150 µmol · L–1 7.01 <.001 3.05-16.14
Sex
Male 1
Female 3.58 <.001 1.83-7.00
Age (y)
<70 1
≥70 2.62 .004 1.36-5.07
Left ventricular function
Ejection fraction ≥ 30% 1
Ejection fraction < 30% 2.74 .006 1.33-5.65
Cardiopulmonary bypass time
For increments of 10 min 1.29 <.001 1.16-1.42
Table VI.  Factors contributing to a 20% or greater
increase in the serum creatinine level in association
with coronary artery bypass grafting with cardiopul-
monary bypass
Covariate Odds ratio P value 95% CI
Preoperative creatinine level
<130 mmol · L–1 1
130-149 mmol · L–1 1.83 .022 1.09-3.09
≥150 mmol · L–1 2.57 .01 1.44-4.56
Hypertension
No 1
Yes 1.39 .007 1.09-1.77
Angina
≤NYHA II 1
≥NYHA III 1.51 .001 1.18-1.93
Surgical priority
Elective 1
Nonelective 1.95 .012 1.16-3.30
Cardiopulmonary bypass time
For increments of 10 min 1.20 <.001 1.08-1.32
longed cardiopulmonary bypass times, increasing the
risk of hemoglobinuria and acute renal dysfunction.
The study was not designed to analyze postoperative
events, and thus a potential weakness is that it does not
investigate their possible contribution to the increase in
serum creatinine levels.
On performing multivariable analysis to include all
the risk factors outlined in Table I, it was seen that the
type of myocardial protection used did not influence
mortality significantly. Similarly, there was no differ-
ence on multivariable analysis between crossclamp fi-
brillation or cardioplegia on the need for mechanical
renal support or on the special care or total postopera-
tive stay. The lowest core body temperature achieved
during the operation also had no independent effect on
morbidity or mortality.
This study confirms clinical observations that the mor-
bidity and mortality from coronary artery bypass graft-
ing increase with even mild-to-moderate elevation of the
preoperative serum creatinine level. The factors that con-
tribute significantly to renal dysfunction as a result of
coronary operation are also outlined. We hope the
insights gained from this study will help in a more rig-
orous design and assessment of strategies aimed at
reducing the increased morbidity and mortality from
coronary artery bypass grafting seen in patients with
non–dialysis-dependent renal dysfunction.
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